C M BIDWELL & ASSOCIATES LTD - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 262 filers reported holding HAEMONETICS CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
C M BIDWELL & ASSOCIATES LTD ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$214,007
+25.9%
2,389
+19.7%
0.16%
+31.5%
Q2 2023$169,939
+2.9%
1,9960.0%0.12%
-0.8%
Q1 2023$165,169
+120.2%
1,996
+166.1%
0.12%
+54.3%
Q4 2018$75,000
-28.6%
750
-18.5%
0.08%
-18.2%
Q3 2018$105,000
+8.2%
920
-15.2%
0.10%
+10.0%
Q2 2018$97,000
+21.2%
1,085
-1.4%
0.09%
+23.3%
Q1 2018$80,0001,1000.07%
Other shareholders
HAEMONETICS CORP shareholders Q1 2018
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders